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Abstract 
The structures of the capsular polysaccharides (CPSs) of the two clinical isolates Acinetobacter 
baumannii SMAL and MG1 were elucidated. Hot phenol/water extractions of the dry biomasses, 
followed by enzymatic digestions and repeated ultracentrifugations led to the isolation of 
polysaccharides which were negative in Western blot analysis utilizing an anti-lipid A antibody, 
thus proving that they were not the LPS O-antigens but CPSs. Their structures were established on 
the basis of NMR spectroscopy and GC-MS analyses. The A. baumannii MG1 CPS consisted of a 
linear aminopolysaccharide with acyl substitution heterogeneity at the N-4 amino group of 
QuipN4N:  
 
4)--D-GlcpNAc-(14)--L-GalpNAcA-(13)--D-QuipNAc4NR-(1 
R= 3-hydroxybutyrryl or acetyl 
 2 
 
The repeating unit of the CPS produced by strain SMAL is a pentasaccharide, already reported for 
the O-antigen moiety from A. baumannii strain ATCC 17961:  
  
    -D-GlcpNAc3NAcA-(1 
 ↓ 
 4) 
6)--D-Glcp-(13)--D-GalpNAc-(13)--D-Galp-(1 
 6) 
 ↑ 
  -D-GlcpNAc-(1 
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1. Introduction 
Acinetobacter baumannii is an opportunistic Gram-negative bacterium and considered the most 
common human pathogen species within its genus, followed by A. lwoffii and A. haemolyticus. This 
bacterium is widely distributed in nature and is extraordinarily adaptable to a variety of 
environmental conditions, e.g., it may colonize a variety of hospital surfaces such as surgical drains 
or aeration filters.1 It is generally considered an opportunistic pathogen in immuno-compromised 
patients causing severe nosocomial, bloodstream, pneumonia, or urinary tract infections, and 
septicemia.2 
The propensity of this organism to develop drug-resistance3 (against carbapenem, beta-lactam, and 
tetracycline antibiotics) and the lack of development of new drugs to treat infections have resulted 
in a significant increase in Acinetobacter-related studies.4 In this regard, the study of the main outer 
membrane components, lipopolysaccharides (LPSs) and capsular polysaccharides (CPSs) is of high 
importance, since these cell wall components may help to prevent bacterial killing and lyses. 
The LPS is composed of the lipid A which is inserted in the bacterial outer membrane and 
substituted by the core region which in turn bears a third, optional region, termed the O-specific 
side chain (OPS, or O-antigen). Consequently, LPSs are classified as S- or R-form (also called 
lipooligosaccharide, LOS), depending on the presence or absence of the O-antigen, respectively. In 
addition to LPS, Acinetobacter bacteria can be surrounded by a thick polysaccharide layer, named 
capsule or K-antigen. 
So far, the LPS structures from several Acinetobacter species have been described, and the 
occurrence of both, R-5,6 and S-form LPSs was reported.7,8 Additionally, more than 10 surface 
polysaccharides were isolated from different A. baumannii strains,9 but in most cases it was not 
clear whether they originated  from CPSs or OPSs. Thus, to date, only two CPSs from 
Acinetobacter species have been clearly defined, namely those of A. calcoaceticus BD410 and to A. 
lwoffii F78.11 
 4 
In this article, the CPS of two clinical isolates of A. baumannii, SMAL and MG1, were investigated 
disclosing the occurrence of two different capsular polysaccharides. These data extend the basis for 
the development of an Acinetobacter serotyping scheme, analogous to that currently used for 
Escherichia coli isolates. 
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2. Results and Discussion 
2.1 Isolation and chemical analysis of supernatants and sediments from A. baumannii MG1 
and SMAL obtained by ultracentrifugation. 
Freeze-dried cells of A. baumannii MG1 and SMAL were treated with aqueous 90% phenol-
chloroform-light petroleum (PCP)12 to extract R-form LPS, and the remaining pellets were 
successively extracted according to the hot phenol/water method.13 The water phases were further 
purified, i.e. nucleic acid and protein contaminants were removed by enzymatic digestion and the 
resulting solutions were dialyzed and subjected to several cycles of ultracentrifugation (UC). Sugar 
analysis of the UC sediments gave the same compositions as identified for the LOSs from the two 
A. baumannii strains, namely D-Glc, D-GalN, D-GlcN, and 3-deoxy-D-manno-oct-2-ulosonic acid 
(Kdo).  
The monosaccharide composition of the UC supernatant from A. baumannii MG1 comprised L-
GalNA, D-QuiN4N (bacillosamine), and D-GlcN. The absolute configuration of QuiN4N was 
assigned using the same sugar obtained from the CPS produced by A. lwoffii F7811 as standard, and 
similarly the GalNA butylglycoside was compared to the analogue derivative obtained from the 
LPS of Halomonas pantelleriensis.14 Furthermore, after weak methanolysis and acetylation, GC-MS 
analysis showed the presence of QuinN4N substituted at N-4 by (S)-3-hydroxybutyrryl group (HB). 
The substituted position was assigned on the basis of the retention time and mass spectrum 
analogies with the same residue identified in the CPS of A. lwoffii F78.11 The sugar composition of 
the UC supernatant from A. baumannii SMAL revealed the presence of D-Gal, D-Glc, D-GlcN, D-
GalN, and 2,3-diacetoamido-2,3-dideoxy-glucuronic acid (DAGA).  
 
2.2 Electrophoretic and Western Blot analysis of UC supernatant and sediment from A. 
baumannii MG1 and SMAL 
The sediments and supernatants from UC were analyzed by SDS-PAGE. The gel was first fixed 
with Alcian blue15 then with silver nitrate,16 and disclosed the occurrence of LOS molecules in the 
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sediment (figure 1), whereas the supernatants contained high molecular mass material which was 
sensitive to Alcian blue (figure 2, lines 1-4) and identified as CPS. Here, the presence of  LOS was 
negligible and was detected only after having overloaded the gel (figure 2, lines 5 and 6). 
In order to exclude that the isolated polysaccharides might originate from LPS, the CPS preparation 
was subjected to Western blot analysis developed after mild acid hydrolysis of the membrane with 
the monoclonal antibody (mAb) A6,17 which specifically recognizes the free bisphosphorylated 
diglucosamine backbone of lipid A. This antibody had been used earlier for the identification of 
non-stainable S-form LPS in various Acinetobacter strains and LOS in A. lwoffii F78.11 The CPS 
isolated from A. baumannii MG1 and SMAL did not bind mAb A6 (figure 3, lines 2 and 3). Only 
when applied in high amounts (figure 3, lines 4 and 5), a very faint smear appeared at the bottom of 
the membrane, with a migration similar to that observed for the purified LOS (figure 3, lines 6 and 
7), confirming its occurrence in trace amounts. The lack of reaction of mAb A6 with the material in 
the upper part of the gel pointed at the presence of a CPS in both, A. baumannii MG1 and SMAL. 
 
2.3 Spectroscopical analyses of the CPS from A. baumanni MG1 
In order to establish the structure of the repeating unit of the CPS of A. baumannii MG1, the UC 
supernatant was analyzed by NMR spectroscopy.  The 1H NMR spectrum (figure 4) contained 
several diagnostic signals: three anomeric ones (5.30-4.50 ppm), and those of four N-acetyl methyl 
protons (approx. 2.00 ppm) and two methyl signals (approx. 1.2 ppm). Of the latter, the most 
intense signal originated from H-6 of the bacillosamine, and the other one was related to HB present 
in non-stoichiometric amounts. The sugar residues were labeled with a letter (A-C) in order of their 
decreasing anomeric chemical shifts, and D corresponded to HB. By analysis of the 2D NMR 
spectra of the polysaccharide all proton and carbon chemical shifts could be assigned (table 1). 
Residue A was classified as a O-4 substituted -GalpNAcA. The galacto stereochemistry was 
identified by the weak scalar correlations in both the COSY and TOCSY spectra of H-4 to its 
vicinal protons (H-3 and H-5), the -configuration was established on the basis of the chemical 
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shift (5.21 ppm) and of the broad singlet shape of the H-1 signal. The chemical shifts of the ring 
carbons identified one nitrogen-bearing carbon, namely C-2 (50.4 ppm), which was N-acetylated as 
proven by the H-2 deshielded chemical shift and by the presence of N-acetyl signals in the proton 
spectrum. The C-4 signal appeared in the low field region of the HSQC spectrum (79.7 ppm) 
proving glycosylation at this position, and H-5 displayed a long-range correlation with a carbon at 
175.1 ppm, confirming the uronic acid feature of this residue. 
Similar considerations identified B as a O-4 substituted 2-acetamido-2-deoxy--glucopyranose. 
With regard to unit C (bacillosamine), the multiplicity of the anomeric proton could not be assigned 
since it appeared as a very broad singlet at 4.60 ppm. Therefore, the -configuration was suggested 
from both the 1H and 13C anomeric chemical shifts and confirmed by the NOE contacts (figure 5) of 
H-1 to both, H-3 and H-5, due to the axial orientation of these three protons. The examination of the 
carbon chemical shifts of this residue identified two nitrogen bearing carbons, i.e. C-2 and C-4 
(both at 57.9 ppm), and the glycosylation site on C-3 (76.8 ppm). 
Using the same approach, the HB residue was completely assigned and, based on the GC-MS data, 
found to substitute the amino group at C-4 of residue C. Information regarding the substitution 
degree at N-4 of C was deduced from the integration of two groups of signals in the high field 
region of the proton spectrum (figure 4), namely the broad peak at 2.33 ppm, which accounted for 
the two methylene protons of HB (Area1), and the two methyl groups (Area2) at 1.24 (H-4 protons 
of HB) and 1.17 ppm (H-6 protons of C). At this regard, methyl signal at 1.17 ppm comprehended 
the methyl protons from all the bacillosamine residues present in the polymer, regardless their 
acylation state on the nitrogen at C-4, that could be either acetylated or substituted with the HB unit. 
This methyl signal could not be integrated directly in the proton spectrum, but its contribute to 
Area2 was deduced applying formula 1: both Area1 and Area2 were normalized with respect to the 
number of protons they represented (two and three, respectively), so that (Area2)/3 represented the 
number of HB residues plus those of bacillosamine, while (Area1)/2 reflected the total number of 
HB moieties. In this way, the bacillosamine amount was deduced subtracting Area1 from Area2 and 
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this value was then compared with that of the HB residue (Area1) yielding an overall substitution 
degree of 19% (see formula 1). 
The analysis of the NOESY spectrum (figure 5) showed a spatial proximity between H-1 of A and 
H-3 of C, H-1 of B and H-4 of A, and H-1 of C and H-4 of B, and thus, disclosed the sequence 
between the three residues as reported in figure 6a. 
Finally, CPS 1H NMR and HSQC spectra were recorded in 10 mM deuterated HCl (data not shown). 
Under this condition a large low field shift was found for H-5 resonance and to a lesser extent for  
H-1 signals of the GalpNAcA residue, suggesting that the carboxylic group of this residue was in 
the free form and amidated, for instance. 
 
2.4 Structural analysis of the CPS from A. baumannii clinical isolated SMAL 
The proton NMR spectrum of the CPS produced by strain SMAL showed five anomeric signals and 
a crowded carbinolic area, together with the occurrence of four N-acetyl methyl signals. The 
analysis of the 2D NMR spectra was impaired by the high number of signals, many of which 
overlapped, and from their broad shape which resulted in poor quality spectra. These problems were 
circumvented by studying the deacetylated CPS and recording the sample under alkaline conditions 
causing the shift of the amino-geminal protons to high field region of the spectrum. 
The five anomeric signals were labeled A - E in decreasing order of their chemical shifts, and the 
attribution of the 2D homo- and heteronuclear spectra (table 2) followed the strategy described 
above for the MG1 CPS and characterized the structure of the repeating unit (figure 7a). 
On the basis of the above information and considering that the alkaline treatment removed the pre-
existing acetyl groups, the structure of the repeating unit of the O-deacylated CPS produced from A. 
baumannii SMAL was as shown in figure 7b. This repeating unit was identical to that previously 
reported for A. baumannii strain ATCC 17961.18 
 
3. Conclusions 
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In the course of this study, carbohydrate material produced from two A. baumannii clinical isolates, 
MG1 and SMAL, was studied with the purpose to establish their location in the cell envelope 
together with their structures. 
Western blot analysis classified these materials as CPSs and the extensive use of NMR 
spectroscopy determined the carbohydrate sequence of each repeating unit. With regard to A. 
baumannii MG1, the repeating unit of the capsular structure is constituted by three different amino 
sugars (figure 6a) and it is quite similar to the O-antigen of the LPS from another strain of A. 
baumannii (figure 6b).19 Indeed, both polymers possess a -bacillosamine residue acylated non-
stoichiometrically with HB at N-4, but they differ in the absolute configuration of the GalpNA 
residue and the acetylation at O-6 of the GlcpN unit, which is absent in the MG1 CPS.  
As far as A. baumannii SMAL is concerned, its CPS is constituted of a pentasaccharide repeating 
unit (figure 7b), rich in amino sugars, as was often found in CPS or O-antigens from this bacterial 
species. The structure of this polysaccharide is not new, and it was recently reported for the O-
antigen of another A. baumannii strain, ATCC 17961.18 
The structures of the CPSs from A. baumannii MG1 and SMAL may contribute to the establishment 
of a serotyping scheme for this bacterium.  
 
4. Experimental 
4.1 Bacteria growth and CPS isolation 
A. baumannii strains SMAL and MG1 were cultivated in Luria Broth (LB) medium at 28°C and 
cells were collected by centrifugation (9 800 g, 20 min, 4°C), washed sequentially with distilled 
water, ethanol, acetone, and ethyl ether, then suspended in water and freeze-dried. 
For each strain, the isolation of the  LOS was performed on dry cells by PCP (2:8:5 v/v/v) 
extraction.12 After removal of the light solvents under vacuum, the LOS was precipitated from the 
phenol with water and washed with aqueous 80% phenol and acetone. The precipitate was 
suspended in water and lyophilized (strain SMAL yield 0.8% gLOS/gcells; strain MG1 yield 0.7% 
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gLOS/gcells). The remaining cell pellet was extracted according to the hot phenol/water protocol,
13 
and water and phenol phases were dialyzed and freeze dried. In both cases, preliminary chemical 
and electrophoretic analysis revealed the presence of polysaccharide material in the water phases 
(strain SMAL yield 22% gLOS/gcells, strain MG1 yield 20% gLOS/gcells). The phenol phases were not 
investigated. 
The CPS were purified from nucleic acid, proteins and LOS by enzymatic treatment and repeated 
ultracentrifugations: for each strain, the crude water extract was solved in the digestion buffer (100 
mM TRIS, 50 mM NaCl, 10 mM MgCl2, buffer at pH 7.5) at a concentration of 5 mg/mL, and 
treated with DNAse (Roche, Germany 04716728001) at 37 °C overnight, successively Proteinase K 
(Roche, Germany 03115836001) was added and the solution left at 56 °C for 4 h. After dialysis and 
freeze-drying, enzyme-treated water phase (30 mg from each strain) was solved in distilled water 
and ultracentrifuged (105 000 g, 4°C for 12 h). The LOS-containing sediment was suspended in 
water and ultracentrifuged again at the same conditions. This sediment was lyophilized and used for 
further analysis (strain SMAL yield 9 mg, strain MG1 13 mg). The CPS-containing supernatants 
were combined and ultracentrifugated (500 000 g, 4°C, 48 h), the supernatant, namely the purified 
CPS, was freeze-dried and finally used for the chemical analyses (strain SMAL yield 18 mg, strain 
MG1 yield 15 mg). 
 
4.2 Chemical Analyses 
Monosaccharide compositional analysis (acetylated methyl glycosides) and absolute configuration 
analysis (octyl or butyl glycosides) were performed as reported elsewhere.20 
Monosaccharide derivatives were recognized on the basis of their GC-MS spectrum fragmentation 
pattern and by comparison of their retention time with that of authentic standards. At this regards, L-
GalpNA, and D-bacillosamine reference compounds were obtained from the LPS of Halomonas 
pantelleriensis14 and CPS of A. lwoffii F78, respectively.11 
 
 
11 
All samples were analysed with a Hewelett-Packard 5890 GC-MS instrument, equipped with a 
SPB-5 capillary column (Supelco, 30 m x 0.25 mm i.d., flow rate, 0.8 mL/min, He as carrier gas) 
and the temperature program: 150 °C for 5 min, 150→300 °C at 10 °C/min, 300 °C for 12 min; 
electronic impact mass spectra were recorded with an ionization energy of 70 eV and an ionizing 
current of 0.2 mA. 
 
4.3 SDS-PAGE and immunodetection analysis 
The sediments and supernatants obtained after UC were subjected to SDS-PAGE21 and Western 
Blot using the anti-lipid A  monoclonal antibody (mAb) A6.17 Discontinuous SDS-PAGE was 
performed on a miniprotean gel system (Bio-Rad) with a 5% stacking gel. The separating gel 
composition was optimized for the type of molecule screened, i.e. 15% for LOS and 8% (top half) 
and 15% (bottom half) for CPS. Samples were run at constant voltage (150 V), and gels were silver 
stained,16 applying Alcian blue first, as fixative.15 
Western blot analysis was accomplished using a Biorad Trans Blot Cell System and a PVDF 
membrane (pore size 0.45 μm). The membrane blotting was performed in Trans-Buffer (Tris 2.4 
g/L, glycin 11.5 g/L, 15% methanol) for 16 h, 10°C, 26 V. The membrane was incubated with 1% 
AcOH (100°C, 2h) to cleave the Kdo glycosidic linkage which was required because mAb A6 is 
specific for free lipid A. 
For Western blot detection, the membrane  was washed with Tris-Tween buffer (3 x 30 min; Tris 
1.21 g/L, Tween 20 0.5 ml/L, pH 8.0) then blocked for 1 h in Tris-Tween buffer with evaporated 
defatted milk (5%) and incubated for 1 h with mAb A6 (diluition 1:200) in dilution buffer 
(Na2HPO4 1.78 g/L, NaCl 8.77 g/L, Tween 20 0.5 ml/L, pH 7.4) and 2% of evaporated defatted 
milk. The membrane was then washed with Tris-Tween buffer (3 x 15 min) and incubated for 1 h 
with the secondary antibody alkaline phosphatase (AP)-conjugated goat anti-mouse IgG (Jackson 
ImmunoResearch cod. 115-055-003, dilution 1:1000). Finally, the membrane was rinsed with Tris-
Tween buffer (2x15 min) first and then with PBS, followed by washing with AP-buffer (10 min, 0.1 
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M NaHCO3, 1 mM MgCl26 H2O, pH 9.0) and treatment with a solution containing NBT (Biomol 
06428, 50 mg/mL in 70% DMF) and BCIP (Biomol 02291, 50 mg/mL in DMF), 2:1, v/v, in AP-
buffer, until the color developed. 
. 
4.5 Deacylation of CPS from A. baumannii SMAL 
Deacylation of both CPS was performed treating the sample (10 mg) with 4 M KOH (1 mL) at 
120°C for 16 h. After neutralization, the sample was desalted by SEC chromatography (Biogel P2, 
Biorad, 1.5 x 120 cm, eluent 50 mM NH4HCO3, flow rate 0.2 mL/min), from which it was 
recovered in the void volume of the column. 
 
4.6 NMR spectroscopy 
Homo-and heteronuclear spectra of the CPS from A. baumannii MG1 were recorded in deuterated 
water (D2O)  using Varian Inova 500 MHz spectrometer equipped with a inverse z-gradient probe 
(Consortium INCA, L488/92, Cluster 11) operating at 298 K. With regard to the CPS of A. 
baumannii SMAL, spectra were acquired on a Bruker 600 MHz equipped with a cryo probe; the 
fully deacetylated capsule (5 mg in 600 l of 30 mM NaOD in D2O) was measured at 291 K. 
Chemical shifts are expressed in ppm relative to internal acetone (1H at 2.225 ppm, 13C at 31.45 
ppm). Two-dimensional spectra (DQ-COSY, TOCSY, NOESY, gHSQC and gHMBC) were 
measured using the standard Varian or Bruker software. For the homonuclear experiment, 512 FIDs 
of 2048 complex data points were collected, with 40 scans per FID, a mixing time of 120 or 200 ms 
was applied for the TOCSY and NOESY spectra, respectively. For the HSQC and HMBC spectra, 
256 FIDS of 2048 complex points were acquired with 50 scans per FID. Processing of the Varian 
and Bruker data and analysis was performed with Bruker TopSpin 2.1 program. 
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Figure Legends 
 
Figure 1: SDS-PAGE (stacking gel 5%, separating gel 15 %), stained with Alcian blue and silver 
nitrate procedure) of the UC sediments; 1: A. b. SMAL (2 μg); 2: A. b. MG1 (2 μg); 3: E. coli O16 
LPS (2 μg)  
 
Figure 2: SDS-PAGE (Stacking gel 5%, separating gel 8 and 15 %) of the UC supernatants; lines 1 
and 2 are stained only with Alcian blue; lines 3-6 are silver stained applying Alcian blue as fixative 
first. 1: A. b. SMAL (1 μg); 2: A. bMG1 (1 μg); 3 and 5: A. b SMAL (1 and 3 μg); 4 and 6: A.b 
MG1 (1and 3 μg).  
 
Figure 3: Western blot of the UC supernatants (lines 2-5) and sediments (lines 6-7) from A. 
baumannii SMAL and MG1, detected with mAb A6. 1: LPS E. coli O16 (8 μg); 2 and 4: UC 
supernatant of A. b. SMAL (5 and 25 μg); 3 and 5: UC supernatant of A. baumannii MG1 (5 and 25 
μg); 6 and 7: UC sediments from A. baumannii SMAL and MG1, respectively (3 μg each).  
 
Figure 4: (500 MHz, 298 K) 1H NMR spectrum in D2O of the capsular polysaccharide from A. 
baumannii MG1. Comparison of Area1 and Area2 according to formula 1, suggested a substitution 
degree with HB at N-4 of the bacillosamine residue of 19%.  
 
Figure 5: The anomeric area of the NOESY spectrum (500 MHz, 298 K) of the CPS from A. 
baumannii MG1 in D2O, the inset shows the NOE contacts identified for residue C. The broad 
anomeric signal of C induced the same pattern in the NOE densities, which appeared large and 
flattened on the baseline; these signals were recognized by amplifying the area of interest, as 
 16 
indicated in the inset. The intra-residue NOE C1,3 may be overestimated due to the coincidence of 
the signals from H-3 of C with H-3 of B. 
 
Figure 6. a) structure of the repeating unit of the capsular polysaccharide from A. baumannii MG1. 
R is HB (19 %) or Acetyl; b) structure of the O-antigen produced from A. baumannii strain 24, R is 
HB or Acetyl. 
 
Figure 7. Structure of the repeating unit of the capsular polysaccharide isolated from  A. baumannii 
SMAL, in its not (a) or acetylated form (b); residue labels reflect those used in the NMR 
assignment. 
 
 
Figure 1: SDS-PAGE (stacking gel 5%, separating gel 15 %, stained with Alcian blue and silver 
nitrate procedure) of ultracentrifuge sediments; 1: A. b. SMAL (2 μg); 2: A.b. MG1 (2 μg); 3: E. coli 
O16 LPS (2 μg)
1 2 3
1 2 3
Figure 2: SDS-PAGE (Stacking gel 5%, separating gel 8 and 15 %) of ultracentrifuge supernatants; lines 
1 and 2
 
are stained only with Alcian blue; lines 3-6
 
are silver stained applying Alcian blue as fixative 
first. 1: A.b. SMAL (1 μg); 2: A.b MG1 (1 μg); 3
 
and 5: A.b SMAL (1 and 3 μg); 4
 
and 6: A.b MG1 (1 and 
3 μg).
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Figure 3: Western blot of ultracentrifuge (UC) supernatants (lines 2-5) and sediments (lines 
6-7) from A. baumannii SMAL and MG1, detected with mAb
 
A6. 1: LPS E. coli O16 (8 μg); 
2
 
and 4: UC supernatant of A. baumannii SMAL (5 and 25 μg); 3
 
and 5: UC supernatant of 
A. baumannii MG1 (5 and 25 μg); 6
 
and 7: UC sediments from A. baumannii SMAL and 
MG1, respectively (3 μg
 
each).
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Figure 4: (500 MHz, 298 K) 1H NMR spectrum of the capsular polysaccharide from A. baumannii 
MG1. Area1
 
represents the integration of the methylene protons from HBA (residue D, Area1
 
); Area2
 
accounts for  all the methyl signals and comprehends H-4s from HBA  (D
 
residue) and H-6s from 
bacillosamine
 
(C
 
residue) regardless the type of N-substitution at C-4  of this last unit (HBA or 
acetyl). Comparison of Area1
 
and Area2
 
according to formula 1,  suggested a substitution degree with 
HBA at N-4 of the bacillosamine
 
residue of 19%.
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Figure 5: The anomeric area of the NOESY spectrum (500 MHz, 298 K) of the CPS from A. 
baumannii MG1, the inset shows the NOE contacts identified for residue C. The broad anomeric 
signal of C
 
induced the same pattern in the NOE densities, which appeared large and flattened on 
the baseline; these signals were recognized by amplifying the area of interest, as indicated in the 
inset. The intra-residue NOE C1,3 maybe overestimated due to the coincidence of the signals from 
H-3 of C
 
with H-3 of B.
Figure 6. a) structure
 
of the repeating unit of the capsular polysaccharide from
 
A. 
baumannii MG1. R is
 
HBA (19 %) or Acetyl; b) structure of the O-antigen produced from 
A. baumannii strain 24, R is HBA or Acetyl.
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Figure 7. Structure of the repeating unit of the capsular polysaccharide isolated from  A. baumannii 
SMAL, in its
 
not
 
(a) or acetylated
 
form
 
(b).
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